All News #Library
Rare Diseases
Longeveron Supports Mikaela Naylon Act & Rare Pediatric Disease
05 Feb 2026 //
GLOBENEWSWIRE
FDA Grants Longeveron Type C Meeting for ELPIS II HLHS Trial
26 Jan 2026 //
GLOBENEWSWIRE
Longeveron CSO Discusses Stem Cell Therapy for HLHS on NPR Defect
27 Oct 2025 //
GLOBENEWSWIRE
FDA OKs Longeveron Phase 2 Laromestrocel Trial in Kids’ DCM
08 Jul 2025 //
GLOBENEWSWIRE
Longeveron Announces Nature Medicine Publication On Ph IIa Trial
11 Mar 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support